Search results

• New Main Page
  ...h an interest in clinical cytogenetics, molecular genetics and genomics in cancer. [[Contact us]] for more information.''' [[File:Circos.png|100px|link=Main_Page]] '''Cancer Genomes''' [[Hematologoic and Lymphoid]] | [[Solid Tumors]] | [[CNS]] | [[P
  7 KB (905 words) - 22:59, 20 November 2017
• All Categories
  == Genes == * Cancer Genes A
  10 KB (1,089 words) - 22:30, 20 November 2017
• The Compendium of Cancer Genome Aberrations
  ...h an interest in clinical cytogenetics, molecular genetics and genomics in cancer.''' ...ermission from the copyright holder, ©International Agency for Research on Cancer.''|alt=]]
  7 KB (1,032 words) - 10:43, 5 March 2024
• Translocation t(14;19)(q32;q13.3)
  == Genes Involved == ...t and t(14;19)(q32;q13) in lymphoproliferative disorders. Genes Chromosome Cancer 15:38–47CrossRef
  4 KB (537 words) - 21:44, 20 July 2016
• KIT
  "KIT Proto-Oncogene Receptor Tyrosine Kinase"; "V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog"; PBT; "Stem C ==Cancer Category/Type==
  7 KB (1,047 words) - 14:32, 12 December 2023
• HAEM5:Mixed-phenotype acute leukaemia with KMT2A rearrangement
  ...page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]]. ==Cancer Category / Type==
  19 KB (2,659 words) - 14:32, 13 December 2023
• Testpage2
  .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
  23 KB (3,285 words) - 15:49, 13 September 2019
• AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray
  .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
  23 KB (3,285 words) - 16:56, 8 August 2020
• TestAMLtable
  .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
  23 KB (3,282 words) - 11:49, 14 June 2019
• Chromophobe renal cell carcinoma
  ...>Diaz JI, Mora LB, Hakam A. The Mainz Classification of Renal Cell Tumors. Cancer Control. 1999 Nov;6(6):571-579</ref> ...ton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 8;26(3):319-30.</ref>
  3 KB (421 words) - 11:29, 22 August 2016
• Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations
  ...Table derived from Pugh et al., 2018 [PMID 30393007] with permission from Cancer Genetics. |'''Genes'''
  17 KB (2,298 words) - 16:42, 22 April 2021
• SRSF2
  ==Cancer Category/Type== ...scular endothelial growth factor (''VEGF'') (Merdzhanova et al., 2010). In cancer, ''SRSF2'' variants have been implicated in leukemia and myeloid disorders
  16 KB (2,281 words) - 14:50, 12 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  14 KB (2,044 words) - 10:09, 27 February 2024
• How to Curate a Disease Page
  Thank you for volunteering to help curate the Compendium of Cancer Genome Aberrations (CCGA)! Your help will make this resource a valuable to ...“Disease pages”. The CCGA is especially interested in the curation fusion genes/mutations that arise in disease, esp. in the hematological cancers. Howeve
  7 KB (1,171 words) - 17:30, 23 April 2019
• MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray
  ...ed from Kanagal-Shawanna et al., 2018 [PMID 30377088] with permission from Cancer Genetics. ...urvival in a cohort of MDS or AML patients treated with azacitidine. Blood Cancer J 2013;3:e155.[https://www.ncbi.nlm.nih.gov/pubmed/24185502]</ref><ref name
  38 KB (5,270 words) - 17:10, 30 April 2020
• HAEM5:Splenic diffuse red pulp small B-cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,651 words) - 14:40, 13 December 2023
• BRST5:Adenoid Cystic Carcinoma
  ==Cancer Category/Type== Breast Cancer / Epithelial Tumours of the Breast
  19 KB (2,737 words) - 13:17, 29 February 2024
• TET2
  ==Cancer Category/Type== ...ET2 and WT1 physically interact, suggesting overlapping pathways for these genes in AML (Wang et al., 2015). ''TET2'' mutations increase the response of low
  26 KB (3,824 words) - 15:01, 12 December 2023
• HAEM5:Langerhans cell histiocytosis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (1,965 words) - 14:30, 13 December 2023
• HAEM5:Classic Hodgkin lymphoma
  Patricia V. Hernandez, M.D., Washington University School of Medicine ==Cancer Category / Type==
  15 KB (2,067 words) - 14:23, 13 December 2023

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)